Europe’s Pharma Sector Faces Increasing ChallengesThe Wall Street Journal: "After a healthy second quarter, Europe's pharmaceutical sector may find itself in trouble in the months ahead as companies face patent expiries, tougher regulation and burdensome health care reforms. There is no single remedy for these problems, experts say, so companies need to devise individual ways to pump up their product pipeline to boost growth and profits. While cost-cutting is essential to protect profit margins, experts say drug makers must also revamp their research operations and tap into new disease areas to stay competitive. Emerging markets are now a key focus, too" (Mijuk and Stovall, 8/25).
This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.